Publication | Open Access
A comprehensive profiling of soluble immune checkpoints from the sera of patients with non‐small cell lung cancer
29
Citations
18
References
2022
Year
TIM-3 and LAG-3 were independent biomarkers for the early diagnosis of NSCLC. The combination of TIM-3, LAG-3, and CD137 could increase the diagnostic accuracy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1